Alumis Inc.'s twice-a-day oral drug totally cleared the skin of telltale red, itchy patches in nearly 39% of 80 ...
16d
MedPage Today on MSNCoronary Plaques Reined in With Coronary Calcium Scans in the PictureFor select risk-enhanced individuals at intermediate risk of coronary artery disease (CAD), researchers found a way to implement coronary artery calcium (CAC) scores and primary prevention statins ...
A prominent Capitol Hill lobbyist dumped by her firm over alleged racist texts was a major Democratic donor who coughed up over $400,000 in contributions to those she was trying to influence and ...
Deep-pocketed investors have adopted a bullish approach towards Amgen AMGN, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...
Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre in Hyderabad. The company will inject an initial investment of $200 ...
Amgen announced its plans to open a "technology and innovation" site in India last year that is focused on increasing the use of AI and data science to support development of new medicines.
In early February, Amgen released financial results for the 4th quarter of 2024, which I was eagerly awaiting. In addition to demonstrating efficacy in the treatment of nasal polyps in Phase 3 ...
Som Chattopadhyay, national executive India, Amgen, said the first 300 employees were hired within 78 days of signing the contract for the new facility and another 300 are to be onboarded soon ...
The US-based drug maker Amgen has set up a new technology and innovation centre in Hyderabad and is planning to invest $200 million through 2025, with additional sustained investments planned ove ...
US drug major Amgen on Monday announced the opening of its new technology and innovation site in Hyderabad. The company said it plans to invest $200 million through 2025, with additional ...
(RTTNews) - Amgen (AMGN) and Kyowa Kirin Co., Ltd. announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluating rocatinlimab, an investigational T-cell rebalancing ...
Also Read: Amgen And Kyowa Kirin’s Rocatinlimab Reduces Eczema Severity In Phase 3 Study Change from baseline in the Quantitative Myasthenia Gravis (QMG) score was also greater for patients in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results